[go: up one dir, main page]

CH454164A - Process for the preparation of basic dibenzooxepine or dibenzothiepin derivatives and their salts - Google Patents

Process for the preparation of basic dibenzooxepine or dibenzothiepin derivatives and their salts

Info

Publication number
CH454164A
CH454164A CH452763A CH452763A CH454164A CH 454164 A CH454164 A CH 454164A CH 452763 A CH452763 A CH 452763A CH 452763 A CH452763 A CH 452763A CH 454164 A CH454164 A CH 454164A
Authority
CH
Switzerland
Prior art keywords
formula
compounds
basic
salts
preparation
Prior art date
Application number
CH452763A
Other languages
German (de)
Inventor
Stach Kurt Ing Dr
Original Assignee
Boehringer & Soehne Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer & Soehne Gmbh filed Critical Boehringer & Soehne Gmbh
Publication of CH454164A publication Critical patent/CH454164A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12[b,e]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/12[b,e]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Description

  

  
 



  Verfahren zur Herstellung basischer   Dibenzooxepin- bzw.    Dibenzothiepin-Derivate und ihrer Salze
Gegenstand des schweizerischen Patentes Nr. 419   172    ist ein Verfahren zur Herstellung basischer Dibenzo  ±b,ei-oxepin-    bzw. -thiepinderivate der Formel I,
EMI1.1     
 in welcher X ein   Sauerstoff-oder    Schwefelatom, R1 und R2 Wasserstoff, Halogen, Trifluormethyl-, Alkyl-, Alkoxy-,   Alkylmercaptox    oder   AcylHReste,    R3 Wasserstoff oder einen niedrigen Alkylrest und A eine basische Gruppe bedeuten, ihrer Salze, welches dadurch gekennzeichnet ist, dass man Dibeno-[b,e]-oxepin- bzw.

   -thi  epin-1 1-one    der Formel II
EMI1.2     
 mit Grignard-Verbuindungen der Formel Hal-Mg-CH2  CH (R)-A    umsetzt und das Reaktionsprodukt mit was  serabspaltendea    Mitteln behandelt, worauf   man    die erhaltenden   Alkylidenverbindungen    (I)   gewünschtenfalls    in ihre Salze oder quartären Ammoniumverbindungen   über-    führt. Als basische Reste A   kommen      hierbei    vorzugsweise tertiäre Aminogruppen in Frage, z. B. Dialkylaminogruppen, oder heterocyclische Reste, wie Piperidino-, Pyrrolidino-,   Morpholino- und    Piperazino-Reste, weiche gegebenenfalls auch substituiert sein können.



   Es wurde   nun gefunden,    dass sich Verbindungen der obigen   Formel 1,    welche als basischen Rest A eine Mono  alkylaminogruppe -NHR4    tragen, in besonders vorteil  hatte    Weise dadurch herstellen lassen, dass man Benzylverbindungen der Formel III,
EMI1.3     
 in weicher R4 eine niedere   ALkylgruppe    bedeutet, mit einem Halogenamieisensäureester Hal-COOR (R =   niedriger    Alkylrest) umsetzt und aus den erhaltenen Verbindungen der Formel IV
EMI1.4     
 die Carbalkoxygruppe hydrolytisch abspaltet.



   Die Umsetzung der Benzylverbindungen (III) mit den Halogenameisensäureestern (z. B. Chlorameisensäure äthylester) wird durch Erhitzen in einem interten Lösungsmittel, z. B. Benzol, bewirkt. Die N-Carblkoxy-Verbin- dungen der Formel IV können ohne besondere Isolierung und Reinigung weiter verarbeitet werden; die hydrolytische Abspaltung der Carbalkoxygruppe kann sowohl in saurem als auch in alkalischem Medium bewirkt werden.



  Die erhaltenen Monoalkylaminoalkylidenverbindungen  können gewünschtenfalls in üblicher Weise in ihre Salze übergeführt werden.



   Die als Ausgangsprodukte benötigten Benzylverbindungen der Formel III sind neu; sie lassen sich nach dem im genannten Patent beschriebenen Verfahren herstellen.



   Beispiel I
11-(3'-Monomethylamino-propyliden)-dibenzo   [b, e]-thiepin   
18,7 g (0,05 Mol) 11-[3'-(N-Benzyl-N-methyl)aminorprpyliden]-dibenzo-[b,e]-thiepin und 16,5 g (0,165 Mol) Chlorameisensäureäthylester erhitzt man in 40 ml Benzol 5 Stunden zum Sieden und entfernt anschliessend im Vakuum auf dem Wasserbad die flüchtigen Anteile. Der so erhaltene Rückstand an rohem 11-[3'-(N-Carbäthoxy-N-methyl)-aminopropyliden]-dibenzo-[b,e]-thiepin wird in 100 ml Eisessig und 100 ml 48%iger Bromwasserstoffsäure 5 Stunden unter Rückflusskühlung erwärmt und im Vakuum der Kolbeninhalt auf ein kleines Volumen eingeengt. Man fügt Wasser und Äther hinzu, trennt die wässrigen sauren Anteile ab, alkalisiert mit verdünnter Natronlauge und extrahiert mit Methylenchlorid.

   Die vereinigten und getrockneten   Meth-    ylenchlorid-Anteile befreit man vom Lösungsmittel und destilliert den Eindampfungsrückstand im Hochvakuum.



  Ausbeute: 10,6 g (= 75% d. Th.) 11-(3'-Monomethylaminopropyliden)-dibenzo-[b,e]-thiepin vom Sdp.0.1 1.77 bis 181 C; Fp. 70-72 C (nach Verreiben mit Ligroin).



   Das auf übliche Weise in   Äther    mit ätherischer Salzsäure hergestellte Hydrochlorid schmilzt bei   234-235     C (aus Isopropanol).



   Beispiel 2
11-(3'-Monomethylamino-propyliden)-dibenzo  [b,e]-oxepin
15 g 11-[3'-(N-Benzyl-N-methyl)-aminopropyliden]dibenzo-[b,e]-oxepin und 14 g Chlorameisensäureäthylester in 35 ml Benzol erhitzt man 5 Stunden zum Sieden und entfernt anschliessend im Vakuum auf dem Wasserbad die flüchtigen Anteile. Die so erhaltene rohe N-Carbäthoxy-N-methyl-aminopropyliden-Vberbindung (14 g) wird in einer Lösung von 16 g Kaliumhydroxyd in 60 ml 96%igen  thanol 5 Stunden unter Rückflusskühlung erwärmt. Nach Zugabe von verdünnter Salzsäure und Äther werden die   wässrig-sauren    Anteile abgetrennt. mit verdünnter Kalilauge alkalisiert und mit Äther extrahiert. Der getrocknete und vom Lösungsmittel befreite Extrakt ergibt bei der Hochvakuumdestillation 7,2 g 11-(3'-Monomethylamino-propyliden)-dibenzo-[b,e]-oxepin vom Sdp. 0,05 mm/158-164 C und Fp. 65-67 C (aus Ligroin).

   Ausbeute; 64.5% d. Th.



  (bezogen auf eingestetzte N-Benzyl-N-methyl-aminopropyliden-Verbindung). Das in üblicher Weise hergestellte Hydrochlorid zeigt einen Fp. von   235-236     C (aus Isopropanol oder   Dioxan/Äther).      



  
 



  Process for the preparation of basic dibenzooxepine or dibenzothiepin derivatives and their salts
The subject of Swiss patent No. 419 172 is a process for the preparation of basic dibenzo ± b, ei-oxepin or thiepine derivatives of the formula I,
EMI1.1
 in which X is an oxygen or sulfur atom, R1 and R2 are hydrogen, halogen, trifluoromethyl, alkyl, alkoxy, alkylmercaptox or acylHR radicals, R3 is hydrogen or a lower alkyl radical and A is a basic group, their salts, which is characterized by that one dibeno- [b, e] -oxepin- resp.

   -thi epin-1 1-one of formula II
EMI1.2
 with Grignard compounds of the formula Hal-Mg-CH2 CH (R) -A and the reaction product is treated with what serabspaltendea agents, whereupon the alkylidene compounds (I) obtained are converted into their salts or quaternary ammonium compounds, if desired. Preferred basic radicals A here are tertiary amino groups, e.g. B. dialkylamino groups, or heterocyclic radicals such as piperidino, pyrrolidino, morpholino and piperazino radicals, which can optionally also be substituted.



   It has now been found that compounds of the above formula 1 which carry a monoalkylamino group -NHR4 as the basic radical A could be prepared in a particularly advantageous manner by benzyl compounds of the formula III,
EMI1.3
 in which R4 denotes a lower alkyl group, is reacted with a halogenamic acid ester Hal-COOR (R = lower alkyl radical) and from the compounds of the formula IV
EMI1.4
 the carbalkoxy group is split off hydrolytically.



   The reaction of the benzyl compounds (III) with the haloformic acid esters (e.g. ethyl chloroformate) is carried out by heating in an inert solvent, e.g. B. benzene causes. The N-carboxy compounds of the formula IV can be processed further without special isolation and purification; the hydrolytic cleavage of the carbalkoxy group can be effected both in an acidic and in an alkaline medium.



  The monoalkylaminoalkylidene compounds obtained can, if desired, be converted into their salts in a customary manner.



   The benzyl compounds of the formula III required as starting materials are new; they can be produced by the process described in the patent mentioned.



   Example I.
11- (3'-Monomethylamino-propylidene) -dibenzo [b, e] -thiepin
18.7 g (0.05 mol) of 11- [3 '- (N-benzyl-N-methyl) aminorprpyliden] -dibenzo- [b, e] -thiepine and 16.5 g (0.165 mol) of ethyl chloroformate are heated in Boil 40 ml of benzene for 5 hours and then remove the volatile components in a vacuum on a water bath. The resulting residue of crude 11- [3 '- (N-carbethoxy-N-methyl) aminopropylidene] -dibenzo- [b, e] -thiepin is refluxed in 100 ml of glacial acetic acid and 100 ml of 48% hydrobromic acid for 5 hours The contents of the flask are reduced to a small volume in vacuo. Water and ether are added, the aqueous acidic components are separated off, made alkaline with dilute sodium hydroxide solution and extracted with methylene chloride.

   The combined and dried methylene chloride components are freed from the solvent and the evaporation residue is distilled in a high vacuum.



  Yield: 10.6 g (= 75% of theory) of 11- (3'-monomethylaminopropylidene) -dibenzo- [b, e] -thiepin with a boiling point of 0.1 1.77 to 181 C; M.p. 70-72 ° C. (after trituration with ligroin).



   The hydrochloride, which is produced in the usual way in ether with ethereal hydrochloric acid, melts at 234-235 C (from isopropanol).



   Example 2
11- (3'-Monomethylamino-propylidene) -dibenzo [b, e] -oxepine
15 g of 11- [3 '- (N-benzyl-N-methyl) aminopropylidene] dibenzo- [b, e] -oxepine and 14 g of ethyl chloroformate in 35 ml of benzene are heated to boiling for 5 hours and then removed in vacuo on the Water bath the volatile components. The crude N-carbethoxy-N-methyl-aminopropylidene compound obtained in this way (14 g) is refluxed for 5 hours in a solution of 16 g of potassium hydroxide in 60 ml of 96% strength ethanol. After adding dilute hydrochloric acid and ether, the aqueous-acidic components are separated off. made alkaline with dilute potassium hydroxide and extracted with ether. The dried extract, freed from solvent, gives 7.2 g of 11- (3'-monomethylamino-propylidene) -dibenzo- [b, e] -oxepine with a boiling point of 0.05 mm / 158-164 ° C. and melting point on high vacuum distillation. 65-67 C (from ligroin).

   Yield; 64.5% d. Th.



  (based on the N-benzyl-N-methyl-aminopropylidene compound used). The hydrochloride prepared in the usual way has a melting point of 235-236 ° C. (from isopropanol or dioxane / ether).

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung basischer Dibenzo-[b,e]oxepin-bzw.-thiepin-Derivate der Formel I, EMI2.1 in welcher X ein Sauerstoff- oder Schwefelatom, R1 und R2 Wasserstoff, Halogen, Trifluormethyl-, Alkyl-, Alkoxy-, Alkylmercatpo- oder Acyl-Reste, R3 Wasserstoff oder einen niedrigen Alkylrest und A eine Monoalkyl- aminogruppe der Formel -NH-R4 bedeuten, wobei R4 eine niedrige Alkylgruppe vorstellt, dadurch gekennzeichnet, dass man Benzylverbindungen der Formel III EMI2.2 mit einem Halogenameisensäureester Hal-COOR (R = niedriger Alkylrest zur Umsetzung bringt und aus den erhaltenen N-Carbalkoxy-Verbindungen der Formel IV EMI2.3 die Carbalkoxygruppe hydrolytisch abspaltet. PATENT CLAIM Process for the preparation of basic dibenzo- [b, e] oxepin or thiepin derivatives of the formula I, EMI2.1 in which X is an oxygen or sulfur atom, R1 and R2 are hydrogen, halogen, trifluoromethyl, alkyl, alkoxy, alkylmercatpo or acyl radicals, R3 is hydrogen or a lower alkyl radical and A is a monoalkyl amino group of the formula -NH-R4 mean, where R4 represents a lower alkyl group, characterized in that benzyl compounds of the formula III EMI2.2 with a haloformic acid ester Hal-COOR (R = lower alkyl radical to react and from the resulting N-carbalkoxy compounds of formula IV EMI2.3 the carbalkoxy group is split off hydrolytically. UNTERANSPRUCH Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man die erhaltenen Monoalkylamino alkylidenverbindungen (I) in ihre Salze überführt. SUBClaim Process according to claim, characterized in that the monoalkylamino alkylidene compounds (I) obtained are converted into their salts.
CH452763A 1962-04-14 1963-04-09 Process for the preparation of basic dibenzooxepine or dibenzothiepin derivatives and their salts CH454164A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB66824A DE1239318B (en) 1962-04-14 1962-04-14 Process for the preparation of basic substituted dibenzo-oxepines or dibenzo-thiepines and their hydrohalides

Publications (1)

Publication Number Publication Date
CH454164A true CH454164A (en) 1968-04-15

Family

ID=6975284

Family Applications (1)

Application Number Title Priority Date Filing Date
CH452763A CH454164A (en) 1962-04-14 1963-04-09 Process for the preparation of basic dibenzooxepine or dibenzothiepin derivatives and their salts

Country Status (7)

Country Link
AT (1) AT244980B (en)
CH (1) CH454164A (en)
DE (1) DE1239318B (en)
DK (1) DK111525B (en)
FR (1) FR3631M (en)
GB (1) GB966015A (en)
LU (1) LU43529A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855462A (en) * 1988-06-17 1989-08-08 Pennwalt Corporation Antihistamines

Also Published As

Publication number Publication date
LU43529A1 (en) 1963-06-10
AT244980B (en) 1966-02-10
DK111525B (en) 1968-09-09
FR3631M (en) 1965-10-25
DE1239318B (en) 1967-04-27
GB966015A (en) 1964-08-06

Similar Documents

Publication Publication Date Title
DE2503815A1 (en) INDAZOLE DERIVATIVES, METHOD FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS
CH648559A5 (en) THEOPHYLINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
CH633249A5 (en) METHOD FOR PRODUCING NEW POLYPRENYL DERIVATIVES.
DE2855703C2 (en) 8-Substituted 3-fluoro-10-piperazino-10,11-dihydrodibenzo[b,f]thiepines, their preparation and pharmaceutical compositions containing them
CH622769A5 (en)
DE1445882A1 (en) Process for the preparation of pyridine derivatives
CH510688A (en) New derivatives of 6 11-dihydro-dibenzo b e-oxepine
CH454164A (en) Process for the preparation of basic dibenzooxepine or dibenzothiepin derivatives and their salts
DE1493451A1 (en) Process for the production of basic dibenzooxepine or. Dibenzothiepine derivatives and their salts
CH436297A (en) Process for the preparation of 11-basic substituted dibenz (b, f) - (1,4) oxazepine
DE1076691B (en) Process for the preparation of phenthiazine derivatives
DE1695812B2 (en) Dibenzo [cfl -1,2-thiazepine derivatives, process for their preparation and pharmaceutical preparation containing them
DE1090667B (en) Process for the preparation of basic phenthiazine derivatives
DE3120909C2 (en) Process for the preparation of 7- (N-ethyl-N-β-hydroxyethylaminoethyl) -8-benzyltheophylline (Bamifylline)
DE2202788A1 (en) New dibenzocyclohepta-dioxolane derivatives and processes for their preparation
DE2618721C2 (en) Benzo (b) bicyclo [3,3,1] nonenes, processes for their preparation and pharmaceutical compositions containing these compounds
DE1151509B (en) Process for the preparation of phenthiazine derivatives
DE1300954B (en) Process for the production of dibenzothiepin and oxepines
DE1161279B (en) Process for the preparation of azepinone derivatives and their salts
AT228794B (en) Process for the preparation of N-heterocyclic compounds
AT217045B (en) Process for the preparation of new monoalkylated or monohalogenated N-derivatives of 10,11-dihydro-5H-dibenzo [b, f] azepines and 5H-dibenzo [b, f] azepines
DE3040085A1 (en) METHOD FOR PRODUCING NEW 10.11-DIHYDRO-5H-DIBENZ (B, F) AZEPINE AND ITS SALTS
DE1620347C3 (en) Process for the production of 5- (dialkyl-aminoalkyl) -5, l 1-dihydrodibenz square bracket to b, square bracket to square bracket to 1,4 square bracket to oxazepines
AT242137B (en) Process for the preparation of new derivatives of 4-aminobutyn- (2, 3) -ol-1 and their salts
DE1470160C (en) 2-chloro-9-piperazinopropylidene-thioxanthenes and a process for their preparation